"We are stronger together! Based in Milwaukee, Versiti Blood Center of Wisconsin (formerly BloodCenter of Wisconsin) combines the strength of blood centers in Wisconsin, Indiana, Illinois, Michigan and Ohio with state-of-the-art diagnostic laboratories, physician services, and a world-renowned Blood Research Institute. Your blood will always stay local first, but now we will have even more access to rare and unique blood types to help meet the needs of Wisconsin hospital patients in need. Together, with you, we promise to continue our mission: we are a beacon of hope. About this location: The visitor parking lot (located on 18th Street) for this location is enclosed by a gate."

During the past decade, Blood Center of Wisconsin conducted 19 clinical trials. In the 10-year time frame, 19 clinical trials started and 12 clinical trials were completed, i.e. on average, 63.2% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 3 clinical trials were completed. i.e. 60% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Blood Center of Wisconsin" #1 sponsor was "Terumo BCT" with 6 trials, followed by "American Thrombosis and Hemostasis Network" with 3 trials sponsored, "Baxalta now part of Shire" with 3 trials sponsored, "Fenwal, Inc." with 2 trials sponsored and "Prolong Pharmaceuticals" with 2 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 22 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Blood Center of Wisconsin" #1 collaborator was "Versiti" with 6 trials as a collaborator, "CSL Behring" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "American National Red Cross" with 2 trials as a collaborator and "Medical College of Wisconsin" with 2 trials as a collaborator. Other collaborators include 29 different institutions and companies that were collaborators in the rest 37 trials.

According to Clinical.Site data, the most researched conditions in "Blood Center of Wisconsin" are "Healthy Volunteers" (4 trials), "Hemophilia B" (4 trials), "Sickle Cell Disease" (3 trials), "Blood Coagulation Disorder" (2 trials) and "Blood Coagulation Disorders, Inherited" (2 trials). Many other conditions were trialed in "Blood Center of Wisconsin" in a lesser frequency.

Most popular intervention types in "Blood Center of Wisconsin" are "Device" (9 trials), "Drug" (9 trials), "Biological" (7 trials), "Dietary Supplement" (2 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Trima Accel System with Version 7.0 Software" (2 trials), "Amicus Red Cell Exchange in SCD patients" (1 trials), "Apixaban 2.5 MG" (1 trials) and "AskBio009" (1 trials). Other intervention names were less common.

The vast majority of trials in "Blood Center of Wisconsin" are 26 trials for "All" genders, 6 trials for "Male" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Blood Center of Wisconsin". undefined are not yet recruiting, 1 are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 28 completed trials in Blood Center of Wisconsin, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Blood Center of Wisconsin, 6 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 6 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 9 trials that are defined as “Not Applicable".